放射治疗在儿童恶性肿瘤治疗中的应用
Application of Radiotherapy in the Treatment of Childhood Cancer
DOI: 10.12677/WJCR.2018.83014, PDF,  被引量   
作者: 张道明：吉林大学第二医院放射肿瘤科，吉林 长春；程丽萍, 曾 辉*：江汉大学第三附属医院黄陂区人民医院放射肿瘤科，湖北 武汉
关键词: 儿童；恶性肿瘤；放疗；Children； Cancer； Radiotherapy
摘要: 儿童恶性肿瘤的治疗原则是根据具体病种和病理类型，通过手术、放疗、化疗以及其他手段联合应用以最大程度杀死肿瘤并改善长期生存质量。放射治疗是儿童恶性肿瘤处理的重要手段，随着放疗技术的发展，其在临床工作中的地位越来越重要。本文简要总结了放疗在儿童肿瘤应用中的特点并介绍放疗在部分主要儿童恶性肿瘤中的应用。
Abstract: The principle of treatment of childhood cancers is to try best to kill tumor cells and improve long-term quality of life based on the specific diseases and pathological types using treatments combined by surgery, radiotherapy, chemotherapy and other methods. With the development of radiotherapy technology, it is an important treatment for childhood cancers and its status in clinical work is more and more important. This article briefly summarizes the characteristics of radi-otherapy in childhood cancer applications and describes the use of radiotherapy in some of the major childhood malignancies.
文章引用：张道明, 程丽萍, 曾辉. 放射治疗在儿童恶性肿瘤治疗中的应用[J]. 世界肿瘤研究, 2018, 8(3): 87-94. https://doi.org/10.12677/WJCR.2018.83014

参考文献

[1] Kram Árová, E. and Stiller, C.A. (2005) International Classification Childhood Cancer. Cancer, 103, 1457-1467.
[Google Scholar] [CrossRef] [PubMed]
[2] 董爽, 于世英. 肿瘤化疗所致恶心呕吐现状调查[J]. 中国循证医学杂志, 2013, 13(6): 687-691.
[3] 萍萍, 吴春晓, 顾凯, 等. 上海市儿童恶性肿瘤发病情况和时间趋势分析[J]. 中华流行病学杂志, 2016, 37(1): 106-110.
[4] Tsuchida, M., Ohara, A., Manabe, A., et al. (2010) Long-Term Results of Tokyo Children’s Cancer Study Group Trials for Childhood Acute Lymphoblastic Leukemia, 1984-1999. Leukemia, 24, 383-396.
[Google Scholar] [CrossRef] [PubMed]
[5] 张萍, 李霞, 王啟瑶. 儿童恶性肿瘤发病高危因素研究进展[J]. 重庆医学, 2017(30): 4288-4292.
[6] Linabery, A.M. and Ross, J.A. (2008) Childhood and Adolescent Cancer Survival in the US by Race and Ethnicity for the Diagnostic Period 1975-1999. Cancer, 113, 2575-2596.
[Google Scholar] [CrossRef] [PubMed]
[7] Ljungman, G., Jakobson, A., Behrendtz, M., et al. (2011) Incidence and Survival Analyses in Children with Solid Tumors Diagnosed in Sweden between 1983 and 2007. Acta Paediatrica, 100, 750-757.
[Google Scholar] [CrossRef] [PubMed]
[8] 智勇, 高黎, 徐国镇, 等. 初治鼻咽癌调强放疗的初步结果[J]. 中华放射肿瘤学杂志, 2006, 15(4): 237-243.
[9] Llen, A.M., Pawlicki, T., Dong, L., et al. (2012) An Evi-dence Based Review of Proton Beam Therapy: The Report of ASTRO’s Emerging Technology Committee. Radiotherapy & Oncology, 103, 8-11.
[Google Scholar] [CrossRef] [PubMed]
[10] Oeffinger, K.C., Eshelman, D.A., Tomlinson, G.E., et al. (2000) Grading of Late Effects in Young Adult Survivors of Childhood Cancer Followed in an Ambulatory Adult Setting. Cancer, 88, 1687-1695.
[Google Scholar] [CrossRef] 
[11] Mulhern, R.K. and Palmer, S.L. (2003) Neurocognitive Late Effects in Pediatric Cancer. Current Problems in Cancer, 27, 177-197.
[Google Scholar] [CrossRef] 
[12] Gurney, J.G., Kadan-Lottick, N.S., Packer, R.J., et al. (2003) Endocrine and Cardiovascular Late Effects among Adult Survivors of Childhood Brain Tumors: Childhood Cancer Survivor Study. Cancer, 97, 663-673.
[Google Scholar] [CrossRef] [PubMed]
[13] Follin, C. and Erfurth, E.M. (2016) Long-Term Effect of Cranial Radio-therapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors. Current Treatment Options in Oncology, 17, 50.
[Google Scholar] [CrossRef] [PubMed]
[14] Hull, M.C., Morris, C.G., Pepine, C.J., et al. (2003) Valvular Dysfunctionand Carotid-Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated with Radiation Therapy. JAMA, 290, 2831-2837.
[Google Scholar] [CrossRef] [PubMed]
[15] Kahn, J.M., Keegan, T.H., Tao, L., et al. (2016) Racial Disparities in the Survival of American Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, and Hodgkin Lymphoma. Cancer, 122, 2723-2730.
[Google Scholar] [CrossRef] [PubMed]
[16] 王国民. 儿童肿瘤放射治疗学[M]. 第2版. 上海: 上海科学出版社, 2007: 138.
[17] Sterzing, F., Hauswald, H., Uhl, M., et al. (2010) Spinal Cord Sparing Reirradiation with Helical Tomotherapy. Cancer, 116, 3961-3968.
[Google Scholar] [CrossRef] [PubMed]
[18] Sandlund, J.T. and Hudson, M.M. (2010) Hematology Treatment Strategies for Pediatric Hodgkin Lymphoma. Nature Reviews Clinical Oncology, 7, 243-244.
[Google Scholar] [CrossRef] [PubMed]
[19] Wolden, S.L., Chen, L., Kelly, K.M., et al. (2012) Long-Term Results of CCG5942: A Randomized Comparison of Chemotherapy with and without Radiotherapy for Children with Hodgkin’s Lymphoma—A Report from the Children’s Oncology Group. Journal of Clinical Oncology, 30, 3174-3180.
[Google Scholar] [CrossRef] 
[20] Dörffel, W., Rühl, U., Lüders, H., et al. (2013) Treatment of Children and Adolescents with Hodgkin Lymphoma without Radiotherapy for Patients in Complete Re-mission after Chemotherapy: Final Results of the Multinational Trial GPOH-HD95. Journal of Clinical Oncology, 31, 1562-1568.
[Google Scholar] [CrossRef] 
[21] Mauz-Körholz, C., Gorde-Grosjean, S., Hasenclever, D., et al. (2007) Resection Alone in 58 Children with Limited Stage, Lymphocyte-Predominant Hodgkin Lympho-ma-Experience from the European Network Group on Pediatric Hodgkin Lymphoma. Cancer, 110, 179-185.
[Google Scholar] [CrossRef] [PubMed]
[22] Mandell, L.R., Wollner, N. and Fuks, Z. (1987) Is Cranial Radiation Necessary for CNS Prophylaxis in Pediatric NHL. International Journal of Radiation Oncology, Biology, Physics, 13, 359-363.
[Google Scholar] [CrossRef] [PubMed]
[23] Cohn, S.L., Pearson, A.D., London, W.B., et al. (2009) The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report. Clinical On-cology, 27, 289-297.
[Google Scholar] [CrossRef] 
[24] DuBois, S.G., Chesler, L., Groshen, S., et al. (2012) Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuro-blastoma: A New Approaches to Neuroblastoma Therapy Trial. Clinical Cancer Research, 18, 2679-2686.
[Google Scholar] [CrossRef] 
[25] Wilson, J.S., Gains, J.E., Moroz, V., Wheathley, K. and Gaze, M.N. (2014) Systematic Review of (131)I-Meta Iodobenzylguanidine Molecular Radiotherapy for Neuroblastoma. European Journal of Cancer, 50, 801-815.
[Google Scholar] [CrossRef] [PubMed]
[26] Abramson, D.H. (2005) Retinoblastoma in the 20th Century: Past Success and Future Challenges the Weisenfeld Lecture. Investigative Ophthalmology & Visual Science, 46, 2684 -2691.
[Google Scholar] [CrossRef] [PubMed]
[27] 陆烨, 童剑萍. 视网膜母细胞瘤的发生机制及诊断和治疗进展[J]. 现代肿瘤医学, 2016, 24(6): 1007-1014.
[28] Hu, X., Fang, Y., Hui, X., Jv, Y. and You, C. (2016) Radiotherapy for Diffuse Brainstem Glioma in Children and Young Adults. The Cochrane Database of Systematic Reviews, 27, CD010439.
[Google Scholar] [CrossRef] 
[29] Hug, E.B., Muenter, M.W., Archambeau, J.O., et al. (2002) Conformal Proton Radiation Therapy for Pediatric Low-Grade Astrocytomas. Strahlentherapie und Onkologie, 178, 10-17.
[Google Scholar] [CrossRef] [PubMed]
[30] Metzger, M.L. and Dame, J.S. (2005) Current Therapy for Wilms’ Tumor. Oncologist, 10, 815-826.
[Google Scholar] [CrossRef] [PubMed]
[31] Pritchard-Jones, K., et al. (2015) Omission of Doxorubicin from the Treatment of Stage II-III, Intermediate-Risk Wilms’ Tumour (SIOP WT 2001): An Open-Label, Non-Inferiority, Randomised Controlled Trial. The Lancet, 386, 1156-1164.
[Google Scholar] [CrossRef] 
[32] Kalapurakal, J.A., Li, S.M., Breslow, N.E., et al. (2003) Influence of Radiation Therapy Delay on Abdominal Tumor Recurrence in Patients with Favorable Histology Wilms’ Tumor Treated on NWTS-3 and NWTS-4: A Report from the National Wilms’ Tumor Study Group. International Journal of Radiation, Oncology, Biology, Physics, 57, 495-499.
[Google Scholar] [CrossRef] 
[33] Ries, L.A.G., Smith, M.A., Gurney, J.G., et al. (1999) Cancer Incidence and Survival among Children and Adolescents. United States SEER Program 1975-1995, National Cancer Institute, SEER Program, NIH Pub. No. 99-4649, Bethesda, 112-122.
[34] Dasgupta, R., Fuchs, J. and Rodeberg, D. (2016) Rhabdomyosarcoma. Seminars in Pediatric Surgery, 25, 276-283.
[Google Scholar] [CrossRef] [PubMed]

为你推荐